Published in Biomed Microdevices on February 01, 2011
Feasibility of a New Technology for Isolating Circulating Tumour Cells (CTC-SMMiL-E) | NCT03979339
Detecting circulating tumor cells: current challenges and new trends. Theranostics (2013) 1.55
Acoustic separation of circulating tumor cells. Proc Natl Acad Sci U S A (2015) 1.48
Rare cell isolation and analysis in microfluidics. Lab Chip (2014) 1.42
Probing circulating tumor cells in microfluidics. Lab Chip (2013) 1.34
Circulating tumors cells as biomarkers: progress toward biomarker qualification. Cancer J (2011) 1.25
Filter characteristics influencing circulating tumor cell enrichment from whole blood. PLoS One (2013) 1.21
Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives. Biomicrofluidics (2013) 1.19
Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications. Pharmacol Ther (2013) 1.15
Size-based hydrodynamic rare tumor cell separation in curved microfluidic channels. Biomicrofluidics (2013) 1.14
Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. ACS Nano (2012) 1.08
Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS One (2013) 1.06
An integrated microfluidic platform for in situ cellular cytokine secretion immunophenotyping. Lab Chip (2012) 1.06
Continuous-flow microfluidic blood cell sorting for unprocessed whole blood using surface-micromachined microfiltration membranes. Lab Chip (2014) 1.05
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer. PLoS One (2013) 1.04
Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study. BMC Cancer (2012) 1.02
Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells. PLoS One (2014) 1.00
Emerging role of nanomaterials in circulating tumor cell isolation and analysis. ACS Nano (2014) 1.00
Rapid isolation of cancer cells using microfluidic deterministic lateral displacement structure. Biomicrofluidics (2013) 1.00
A pillar-based microfilter for isolation of white blood cells on elastomeric substrate. Biomicrofluidics (2013) 0.99
Point-of-care technologies for molecular diagnostics using a drop of blood. Trends Biotechnol (2014) 0.99
Surface-micromachined microfiltration membranes for efficient isolation and functional immunophenotyping of subpopulations of immune cells. Adv Healthc Mater (2013) 0.97
Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system. Biomed Microdevices (2013) 0.97
Continuous enrichment of low-abundance cell samples using standing surface acoustic waves (SSAW). Lab Chip (2014) 0.95
Photolithographic surface micromachining of polydimethylsiloxane (PDMS). Lab Chip (2011) 0.95
Filtration parameters influencing circulating tumor cell enrichment from whole blood. PLoS One (2013) 0.94
CTC enumeration and characterization: moving toward personalized medicine. Ann Transl Med (2014) 0.94
Progress in circulating tumor cell capture and analysis: implications for cancer management. Expert Rev Mol Diagn (2012) 0.92
Spatially gradated segregation and recovery of circulating tumor cells from peripheral blood of cancer patients. Biomicrofluidics (2013) 0.92
Highly selective biomechanical separation of cancer cells from leukocytes using microfluidic ratchets and hydrodynamic concentrator. Biomicrofluidics (2013) 0.91
Circulating tumor cell enrichment based on physical properties. J Lab Autom (2013) 0.90
Cascaded spiral microfluidic device for deterministic and high purity continuous separation of circulating tumor cells. Biomicrofluidics (2014) 0.88
Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells. PLoS One (2014) 0.88
Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer? J Transl Med (2013) 0.88
Predicting therapy response in live tumor cells isolated with the flexible micro spring array device. Cell Cycle (2013) 0.88
Minimal residual disease and circulating tumor cells in breast cancer. Breast Cancer Res (2011) 0.87
Emerging microfluidic tools for functional cellular immunophenotyping: a new potential paradigm for immune status characterization. Front Oncol (2013) 0.87
Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology. Oncotarget (2016) 0.86
Detection and cultivation of circulating tumor cells in gastric cancer. Cytotechnology (2015) 0.85
Microscale magnetic field modulation for enhanced capture and distribution of rare circulating tumor cells. Sci Rep (2015) 0.84
Development of a new rapid isolation device for circulating tumor cells (CTCs) using 3D palladium filter and its application for genetic analysis. PLoS One (2014) 0.83
A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells. Methods (2013) 0.83
Separable bilayer microfiltration device for viable label-free enrichment of circulating tumour cells. Sci Rep (2014) 0.82
Biosensors for the detection of circulating tumour cells. Sensors (Basel) (2014) 0.81
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples. PLoS One (2016) 0.81
A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay. PLoS One (2015) 0.81
Microfluidics and cancer: are we there yet? Biomed Microdevices (2013) 0.80
Benchtop technologies for circulating tumor cells separation based on biophysical properties. Biomed Res Int (2015) 0.80
Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer. Oncotarget (2016) 0.80
Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics. BMC Cancer (2016) 0.80
Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions. Front Oncol (2015) 0.79
Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential. Mol Diagn Ther (2014) 0.79
Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma. Biosens Bioelectron (2013) 0.79
Biodegradable nano-films for capture and non-invasive release of circulating tumor cells. Biomaterials (2015) 0.78
Development of on-chip multi-imaging flow cytometry for identification of imaging biomarkers of clustered circulating tumor cells. PLoS One (2014) 0.77
Rational Design of Materials Interface for Efficient Capture of Circulating Tumor Cells. Adv Sci (Weinh) (2015) 0.77
Circulating tumor cells isolation: the "post-EpCAM era". Chin J Cancer Res (2015) 0.76
Cup-shaped superparamagnetic hemispheres for size-selective cell filtration. Sci Rep (2014) 0.76
The potential for liquid biopsies in the precision medical treatment of breast cancer. Cancer Biol Med (2016) 0.76
A Size-Selective Intracellular Delivery Platform. Small (2016) 0.75
Recent Progress of Microfluidics in Translational Applications. Adv Healthc Mater (2016) 0.75
Fast and selective cell isolation from blood sample by microfiber fabric system with vacuum aspiration. Sci Technol Adv Mater (2016) 0.75
Label-free single-cell separation and imaging of cancer cells using an integrated microfluidic system. Sci Rep (2017) 0.75
Metastasis and Circulating Tumor Cells. EJIFCC (2012) 0.75
Enrichment and single-cell analysis of circulating tumor cells. Chem Sci (2016) 0.75
Circulating Tumor Cells: From Theory to Nanotechnology-Based Detection. Front Pharmacol (2017) 0.75
Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus. Oncol Rep (2014) 0.75
A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus. Mol Cancer Ther (2015) 0.75
Surface micromachining of polydimethylsiloxane for microfluidics applications. Biomicrofluidics (2016) 0.75
Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back. Int J Mol Sci (2016) 0.75
Liquid biopsy genotyping in lung cancer: ready for clinical utility? Oncotarget (2017) 0.75
Clogging-free microfluidics for continuous size-based separation of microparticles. Sci Rep (2016) 0.75
Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion. PLoS One (2017) 0.75
Change in number and size of circulating tumor cells with high telomerase activity during treatment of patients with gastric cancer. Oncol Lett (2016) 0.75
Selective Adhesive Cell Capture without Molecular Specificity: New Surfaces Exploiting Nanoscopic Polycationic Features as Discrete Adhesive Units. RSC Adv (2017) 0.75
Single-Cell Mechanical Characteristics Analyzed by Multiconstriction Microfluidic Channels. ACS Sens (2017) 0.75
Circulating Tumor Cells: Moving Biological Insights into Detection. Theranostics (2017) 0.75
Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device. Oncotarget (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med (2004) 27.92
Cancer metastasis: building a framework. Cell (2006) 19.67
Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature (2007) 19.33
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res (2004) 14.53
Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med (2008) 13.54
Tumor metastasis: mechanistic insights and clinical challenges. Nat Med (2006) 11.06
Cancer stem cells: an old idea--a paradigm shift. Cancer Res (2006) 9.76
Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer (2008) 7.99
Thermoelasticity of large lecithin bilayer vesicles. Biophys J (1981) 6.92
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res (2007) 6.59
Dissecting the metastatic cascade. Nat Rev Cancer (2004) 6.32
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol (2005) 6.18
Novel Filter for Biological Materials. Science (1964) 5.75
Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol (2000) 5.26
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res (2006) 4.95
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. Clin Cancer Res (2006) 4.86
Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A (1998) 4.76
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer (2007) 4.06
Illuminating the metastatic process. Nat Rev Cancer (2007) 3.80
Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res (2010) 3.61
Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A (2007) 3.48
The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br J Cancer (2006) 2.14
Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res (2008) 2.06
Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol (1991) 2.05
Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices (2009) 2.00
Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. Exp Hematol (2004) 1.83
Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage. Breast Cancer Res Treat (2004) 1.78
Is there a role for circulating tumor cells in the management of breast cancer? Clin Cancer Res (2008) 1.67
Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer (2008) 1.63
uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues. Proc Natl Acad Sci U S A (2006) 1.61
Cell and protein compatibility of parylene-C surfaces. Langmuir (2007) 1.58
Mechanics and thermodynamics of biomembranes: part 1. CRC Crit Rev Bioeng (1979) 1.52
Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology (2004) 1.48
Circulating and disseminated tumor cells. J Clin Oncol (2005) 1.43
Size-selective microcavity array for rapid and efficient detection of circulating tumor cells. Anal Chem (2010) 1.40
Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells. Cytometry A (2003) 1.25
Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res (1993) 1.22
A SIEVE FOR THE ISOLATION OF CANCER CELLS AND OTHER LARGE CELLS FROM THE BLOOD. Cancer (1964) 1.12
Particle track etching. Science (1972) 1.11
Effects of acetone, methanol, or paraformaldehyde on cellular structure, visualized by reflection contrast microscopy and transmission and scanning electron microscopy. Appl Immunohistochem Mol Morphol (2001) 1.11
Tracks of Charged Particles in Solids. Science (1965) 1.11
Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy? Proc Natl Acad Sci U S A (2006) 1.07
Detection of rare circulating breast cancer cells by filtration cytometry and identification by DNA content: sensitivity in an experimental model. Anticancer Res (1997) 1.06
Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood. Am J Pathol (2002) 0.99
Biomechanical interactions of cancer cells with the microvasculature during metastasis. Cell Biophys (1989) 0.98
Detection of circulating melanoma cells by immunomagnetic cell sorting. J Clin Lab Anal (1999) 0.94
Novel technologies and recent advances in metastasis research. Int J Dev Biol (2004) 0.90
Mechanically induced trauma suffered by cancer cells in passing through pores in polycarbonate membranes. Invasion Metastasis (1985) 0.88
Genomics and circulating tumor cells: promising tools for choosing and monitoring adjuvant therapy in patients with early breast cancer? Curr Opin Oncol (2005) 0.80
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol (2006) 25.12
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med (2007) 8.02
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res (2006) 5.21
Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation (2009) 4.71
Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res (2010) 3.61
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status. J Clin Oncol (2011) 3.59
Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A (2007) 3.48
Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules. Eur J Nucl Med Mol Imaging (2013) 2.95
Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis (2010) 2.85
Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol (2006) 2.55
Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation (2011) 2.52
Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res (2007) 2.52
Randomised controlled trial of support from volunteer counsellors for mothers considering breast feeding. BMJ (2004) 2.51
Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med (2007) 2.42
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry (2013) 2.30
Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr (2009) 2.29
Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res (2006) 2.21
Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. J Clin Oncol (2014) 2.19
DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem (2002) 2.16
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol (2006) 2.14
p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer. J Clin Oncol (2007) 2.14
Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods (2008) 2.03
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS (2012) 2.02
Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol (2004) 2.00
Secure encapsulation and publication of biological services in the cloud computing environment. Biomed Res Int (2013) 1.98
Complementary detection of prostate-specific antigen using In2O3 nanowires and carbon nanotubes. J Am Chem Soc (2005) 1.97
Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93
Optimal multivariate matching before randomization. Biostatistics (2004) 1.85
Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron (2007) 1.84
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis (2011) 1.83
Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. Eur Urol (2009) 1.79
Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol (2009) 1.79
DNA extraction from archival formalin-fixed, paraffin-embedded tissues: heat-induced retrieval in alkaline solution. Histochem Cell Biol (2004) 1.77
Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol (2007) 1.74
Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer. Clin Cancer Res (2006) 1.73
Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J Clin Invest (2005) 1.70
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A (2013) 1.67
Development of a multi-electrode array for spinal cord epidural stimulation to facilitate stepping and standing after a complete spinal cord injury in adult rats. J Neuroeng Rehabil (2013) 1.63
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. AIDS (2009) 1.60
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers. J Urol (2011) 1.59
Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol (2008) 1.58
Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J Biol Chem (2006) 1.55
Enhanced radiation damage of tumor vasculature by mTOR inhibitors. Oncogene (2005) 1.54
Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer. Mol Cancer Ther (2006) 1.53
Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model. Clin Cancer Res (2009) 1.53
Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program. Cancer (2013) 1.51
Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc Natl Acad Sci U S A (2004) 1.49
Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy (2008) 1.49
Surface micromachined electrostatically actuated micro peristaltic pump. Lab Chip (2004) 1.46
A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine. Eur J Cancer (2013) 1.45
XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene (2004) 1.44
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer. BMC Cancer (2006) 1.44
p53 predictive value for pT1-2 N0 disease at radical cystectomy. J Urol (2009) 1.43
A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol (2012) 1.42
Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol (2010) 1.40
Ambient air particulate matter exposure and tissue factor expression in atherosclerosis. Inhal Toxicol (2008) 1.40
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer (2008) 1.39
A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. Cancer Res (2010) 1.37
Generation of a concise gene panel for outcome prediction in urinary bladder cancer. J Clin Oncol (2009) 1.32
The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunol Rev (2005) 1.30
Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. Int J Radiat Oncol Biol Phys (2006) 1.30
Circulating tumor cells: from bench to bedside. Annu Rev Med (2012) 1.29
A new multi-site probe array with monolithically integrated parylene flexible cable for neural prostheses. Conf Proc IEEE Eng Med Biol Soc (2005) 1.27
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer. Clin Cancer Res (2009) 1.27
Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin Cancer Res (2008) 1.25
Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions. Cancer Res (2008) 1.24
An electrochemical pumping system for on-chip gradient generation. Anal Chem (2004) 1.24
ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo. Cancer Res (2007) 1.23
Calreticulin-dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules. EMBO J (2009) 1.23
Microelectronic packaging for retinal prostheses. IEEE Eng Med Biol Mag (2005) 1.23
Evaluation of the value of frozen tissue section used as "gold standard" for immunohistochemistry. Am J Clin Pathol (2008) 1.21
High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis. J Mol Diagn (2009) 1.21
Disseminated and circulating tumor cells: Role in effective cancer management. Crit Rev Oncol Hematol (2010) 1.20
Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. Med Phys (2007) 1.20
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer (2005) 1.16
Fatty acid consumption and risk of fracture in the Women's Health Initiative. Am J Clin Nutr (2010) 1.16
p53 and retinoblastoma pathways in bladder cancer. World J Urol (2007) 1.16
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J Urol (2010) 1.15
Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation. Pharmacogenomics (2006) 1.14
Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes. ACS Nano (2009) 1.14
Regulated cell death pathways: new twists in modulation of BCL2 family function. Mol Cancer Ther (2009) 1.13
Molecular markers for bladder cancer: the road to a multimarker approach. Expert Rev Anticancer Ther (2007) 1.13
Global distribution of outbreaks of water-associated infectious diseases. PLoS Negl Trop Dis (2012) 1.12
Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation. Clin Cancer Res (2005) 1.11
The effect of voluntary exercise exposure on histological and neurobehavioral outcomes after ischemic brain injury in the rat. Physiol Behav (2003) 1.11
Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol (2003) 1.11